Skip to main content
. 2013 Dec 20;33(1):6–14. doi: 10.5414/NP300730

Box B. Clinical indications for MGMT promoter methylation testing.

MGMT promoter methylation testing by means of pyrosequencing fulfills the criteria of high clinical utility for predictive purposes in elderly glioblastoma and for prognostic purposes in all adult glioblastoma patients (Table 3).